The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The Bond star paid tribute to Christina Knudsen after her death from cancer aged 47.
Thirteen years later, it's time to reunite with Adam, Pete, Jenny, Karen and David. Here is the first glimpse of the stars back in action.
Former leading amateur jockey JT McNamara has died aged 41